A recent study published in the British Medical Journal found that results of oncology clinical trials published in major medical journals were described using vague terms that downplayed harms associated with cancer drugs, which was at odds with side effects observed in the actual data.  Journalists also use these “vague terms” that minimize potential harms, while emphasizing and exaggerating the potential benefits of new health care interventions. (healthnewsreview.org)